TSS
NVO

Two Sigma Securities’s Novo Nordisk NVO Stock Holding History

Two Sigma Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,400
Closed -$378K – 1981
2024
Q4 		$378K Sell
4,400
-35,200
-89% -$3.81M 0.05% 512
2024
Q3 		$4.72M Buy
39,600
+17,100
+76% +$2.28M 0.08% 296
2024
Q2 		$3.21M Sell
22,500
-5,300
-19% -$702K 0.04% 511
2024
Q1 		$3.57M Sell
27,800
-44,800
-62% -$5.33M 0.03% 508
2023
Q4 		$7.51M Buy
72,600
+62,600
+626% +$6.19M 0.07% 265
2023
Q3 		$909K Buy
10,000
+7,200
+257% +$634K 0.01% 1107
2023
Q2 		$227K Buy
+2,800
New +$229K ﹤0.01% 2111
2022
Q4 		– Sell
-12,200
Closed -$608K – 3056
2022
Q3 		$608K Buy
12,200
+7,200
+144% +$386K 0.02% 942
2022
Q2 		$279K Buy
+5,000
New +$277K 0.01% 1372
2022
Q1 		– Sell
-8,000
Closed -$448K – 2378
2021
Q4 		$448K Buy
+8,000
New +$433K 0.02% 593
2021
Q1 		– Sell
-7,000
Closed -$244K – 1478
2020
Q4 		$244K Buy
+7,000
New +$242K 0.01% 1218
2020
Q1 		– Sell
-15,600
Closed -$451K – 2012
2019
Q4 		$451K Buy
15,600
+1,600
+11% +$44.3K ﹤0.01% 1510
2019
Q3 		$362K Buy
+14,000
New +$354K ﹤0.01% 1413
2018
Q4 		– Sell
-14,400
Closed -$339K – 2615
2018
Q3 		$339K Buy
14,400
+1,400
+11% +$34.2K ﹤0.01% 1670
2018
Q2 		$300K Sell
13,000
-7,800
-38% -$185K ﹤0.01% 2063
2018
Q1 		$512K Buy
20,800
+6,200
+42% +$163K ﹤0.01% 1644
2017
Q4 		$392K Buy
+14,600
New +$371K 0.01% 844

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Securities's NVO Position: Q4 2025 in Review

Two Sigma Securities sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 18,291 shares — an estimated $1.01M sold.

Two Sigma Securities first reported a position in NVO in Q4 2016 and held it in 19 quarters. The position peaked at $15.5M in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Two Sigma Securities reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 18,291 Novo Nordisk shares in Q4 2025, an estimated $1.01M.
  • Two Sigma Securities first reported a position in Novo Nordisk in Q4 2016 and held it in 19 quarters.
  • Two Sigma Securities's Novo Nordisk position peaked at $15.5M in Q2 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.